These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7051804)

  • 1. An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advances breast cancer undergoing oophorectomy: a later analysis.
    Ahmann DL; Green SJ; Bisel HF; Ingle JN; Hahn RG; Lee RA; Edmonson JH
    Am J Clin Oncol; 1982 Aug; 5(4):355-8. PubMed ID: 7051804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy.
    Ahmann DL; O'Connell MJ; Hahn RG; Bisel HF; Lee RA; Edmonson JH
    N Engl J Med; 1977 Aug; 297(7):356-60. PubMed ID: 876327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
    Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW
    J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
    Ingle JN; Everson LK; Wieand HS; Cullinan SA; Wold LE; Hagen JB; Martin JK; Krook JE; Fitzgibbons RG; Foley JF
    Cancer; 1989 Apr; 63(7):1257-64. PubMed ID: 2646004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trial.
    Tormey DC; Gray R; Gilchrist K; Grage T; Carbone PP; Wolter J; Woll JE; Cummings FJ
    Cancer; 1990 Jan; 65(2):200-6. PubMed ID: 2403834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer (1965); 1980 Dec; 16(12):1621-5. PubMed ID: 7014228
    [No Abstract]   [Full Text] [Related]  

  • 10. Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer.
    Ahmann DL; Scanlon PW; Bisel HF; Edmonson JH; Frytak S; Payne WS; O'Fallon JR; Hahn RG; Ingle JN; O'Connell MJ; Rubin J
    Lancet; 1978 Apr; 1(8070):893-6. PubMed ID: 76842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
    Goldhirsch A; Gelber R
    NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.
    Wendt AG; Jones SE; Salmon SE
    Cancer Treat Rep; 1980; 64(2-3):269-73. PubMed ID: 6893293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone alternating with cytoxan and adriamycin.
    Nemoto T; Horton J; Simon R; Dao TL; Rosner D; Cunningham T; Sponzo R; Snyderman M
    Cancer; 1982 May; 49(10):1988-93. PubMed ID: 7074523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
    Carter SK
    Postgrad Med; 1985 Jan; 77(1):75-7, 80-3. PubMed ID: 3880891
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
    Ludwig Breast Cancer Study Group
    J Clin Oncol; 1985 Aug; 3(8):1059-67. PubMed ID: 2862223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.
    Ahmann DL; O'Fallon JR; Scanlon PW; Payne WS; Bisel HF; Edmonson JH; Frytak S; Hahn RG; Ingle JN; Rubin J; Creagan ET
    Am J Clin Oncol; 1982 Aug; 5(4):371-81. PubMed ID: 7051805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
    Scholl SM; Fourquet A; Asselain B; Pierga JY; Vilcoq JR; Durand JC; Dorval T; Palangié T; Jouve M; Beuzeboc P
    Eur J Cancer; 1994; 30A(5):645-52. PubMed ID: 8080680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
    Goldhirsch A; Gelber RD; Castiglione M
    J Clin Oncol; 1988 Jan; 6(1):89-97. PubMed ID: 3275752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
    Goldhirsch A; Gelber RD; Price KN; Castiglione M; Coates AS; Rudenstam CM; Collins J; Lindtner J; Hacking A; Marini G
    Lancet; 1994 Feb; 343(8894):377-81. PubMed ID: 7905550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.